Search research articles
Contact Us
Filters
Showing results (11-20 of 216) with videos related to
Page
of 22
Sort By:
Molecular Pharmacology
|
June 18, 2005
Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation
Eun Ju Bae, Sang Geon Kim
Archives of Pharmacal Research
|
July 13, 2014
Autophagy and microRNA dysregulation in liver diseases
Kyu Min Kim, Sang Geon Kim
Safety and Health at Work
|
September 7, 2012
Clinical outcomes of occupational exposure to n,n-dimethylformamide: perspectives from experimental toxicology
Tae Hyun Kim, Sang Geon Kim
Hepatology (Baltimore, Md.)
|
February 26, 2003
Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway
Min Kyung Cho, Sang Geon Kim
Molecular Pharmacology
|
October 26, 2005
Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation
Seung Jin Lee, Sang Geon Kim
Methods in Enzymology
|
November 18, 2005
G-protein signaling in iNOS gene expression
Sang Geon Kim, Chang Ho Lee
Molecular Endocrinology (Baltimore, Md.)
|
October 24, 2008
A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GR
Il Je Cho, Sang Geon Kim
Archives of Pharmacal Research
|
November 28, 2022
Non-alcoholic fatty liver disease and liver secretome
Muhammad Sohaib Khan, Choongho Lee, Sang Geon Kim
Archives of Pharmacal Research
|
January 6, 2019
Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma
Mi Jeong Heo, Jessica Yun, Sang Geon Kim
Clinical and Molecular Hepatology
|
October 2, 2024
Roles of X-box binding protein 1 in liver pathogenesis
Jihoon Tak, Yun Seok Kim, Sang Geon Kim
Page
of 22
Search research articles
Search
Showing results (11-20 of 216) with videos related to
Sort By:
Page
of 22
Molecular Pharmacology
|
June 18, 2005
Enhanced CCAAT/enhancer-binding protein beta-liver-enriched inhibitory protein production by Oltipraz, which accompanies CUG repeat-binding protein-1 (CUGBP1) RNA-binding protein activation, leads to inhibition of preadipocyte differentiation
Eun Ju Bae, Sang Geon Kim
Archives of Pharmacal Research
|
July 13, 2014
Autophagy and microRNA dysregulation in liver diseases
Kyu Min Kim, Sang Geon Kim
Safety and Health at Work
|
September 7, 2012
Clinical outcomes of occupational exposure to n,n-dimethylformamide: perspectives from experimental toxicology
Tae Hyun Kim, Sang Geon Kim
Hepatology (Baltimore, Md.)
|
February 26, 2003
Hepatocyte growth factor activates CCAAT enhancer binding protein and cell replication via PI3-kinase pathway
Min Kyung Cho, Sang Geon Kim
Molecular Pharmacology
|
October 26, 2005
Role of p90 ribosomal S6-kinase-1 in oltipraz-induced specific phosphorylation of CCAAT/enhancer binding protein-beta for GSTA2 gene transactivation
Seung Jin Lee, Sang Geon Kim
Methods in Enzymology
|
November 18, 2005
G-protein signaling in iNOS gene expression
Sang Geon Kim, Chang Ho Lee
Molecular Endocrinology (Baltimore, Md.)
|
October 24, 2008
A novel mitogen-activated protein kinase phosphatase-1 and glucocorticoid receptor (GR) interacting protein-1-dependent combinatorial mechanism of gene transrepression by GR
Il Je Cho, Sang Geon Kim
Archives of Pharmacal Research
|
November 28, 2022
Non-alcoholic fatty liver disease and liver secretome
Muhammad Sohaib Khan, Choongho Lee, Sang Geon Kim
Archives of Pharmacal Research
|
January 6, 2019
Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma
Mi Jeong Heo, Jessica Yun, Sang Geon Kim
Clinical and Molecular Hepatology
|
October 2, 2024
Roles of X-box binding protein 1 in liver pathogenesis
Jihoon Tak, Yun Seok Kim, Sang Geon Kim
Page
of 22